A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer

Author:

Iwata Hiroji,Masuda Norikazu,Ohno Shinji,Rai Yoshiaki,Sato Yasuyuki,Ohsumi Shozo,Hashigaki Satoshi,Nishizawa Yoshinori,Hiraoka Masahiro,Morimoto Tadaoki,Sasano Hironobu,Saeki Toshiaki,Noguchi Shinzaburo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference44 articles.

1. American Cancer Society (2011) Cancer Facts & Figures 2011. American Cancer Society. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf . Accessed 4 October 2012

2. Ohno Y, Nakamura T, Murata K, Tsukuma H, Ajiki W, Oshima A (2004) Prediction of cancer incidence in Japan. In: Oshima A, Kuroishi T, Tajima K (eds) Cancer Statistics-2004. Shinohara Shuppan, Tokyo, pp 201–217

3. Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1899–1905. doi: 10.1158/1055-9965.EPI-06-0191

4. Bhatnagar AS (2007) The discovery and mechanism of action of letrozole. Breast Cancer Res Treat 105(Suppl 1):7–17

5. Johnston SR (2005) Endocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer—have they lost their way? Breast Cancer Res 7(3):119–130

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3